Definitive Healthcare Corp. (NASDAQ:DH) Shares Sold by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. lowered its stake in shares of Definitive Healthcare Corp. (NASDAQ:DH) by 3.6% in the fourth quarter, Holdings Channel reports. The firm owned 420,493 shares of the company’s stock after selling 15,639 shares during the period. Charles Schwab Investment Management Inc.’s holdings in Definitive Healthcare were worth $1,728,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of DH. State Street Corp boosted its stake in Definitive Healthcare by 29.4% during the 3rd quarter. State Street Corp now owns 1,399,729 shares of the company’s stock worth $6,257,000 after purchasing an additional 317,952 shares during the last quarter. 272 Capital LP boosted its position in Definitive Healthcare by 74.8% during the third quarter. 272 Capital LP now owns 1,114,080 shares of the company’s stock worth $4,980,000 after acquiring an additional 476,766 shares during the last quarter. New York State Common Retirement Fund grew its stake in Definitive Healthcare by 3.2% during the 4th quarter. New York State Common Retirement Fund now owns 771,792 shares of the company’s stock valued at $3,172,000 after acquiring an additional 23,815 shares in the last quarter. Bank of New York Mellon Corp raised its holdings in Definitive Healthcare by 35.9% in the 4th quarter. Bank of New York Mellon Corp now owns 229,143 shares of the company’s stock valued at $942,000 after acquiring an additional 60,559 shares during the last quarter. Finally, JPMorgan Chase & Co. lifted its stake in Definitive Healthcare by 431.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 222,090 shares of the company’s stock worth $993,000 after purchasing an additional 180,323 shares in the last quarter. 98.67% of the stock is owned by hedge funds and other institutional investors.

Definitive Healthcare Stock Down 0.7 %

Shares of NASDAQ:DH opened at $2.94 on Friday. The company has a market capitalization of $331.96 million, a price-to-earnings ratio of -0.95, a PEG ratio of 4.06 and a beta of 1.51. Definitive Healthcare Corp. has a 12-month low of $2.55 and a 12-month high of $8.35. The business has a 50-day moving average price of $4.09 and a 200 day moving average price of $4.26. The company has a current ratio of 2.49, a quick ratio of 2.49 and a debt-to-equity ratio of 0.33.

Definitive Healthcare (NASDAQ:DH) last released its quarterly earnings results on Thursday, February 27th. The company reported $0.03 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.04). Definitive Healthcare had a negative net margin of 142.38% and a positive return on equity of 1.76%. The company had revenue of $62.29 million during the quarter, compared to analysts’ expectations of $60.60 million. Sell-side analysts expect that Definitive Healthcare Corp. will post 0.16 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on DH. The Goldman Sachs Group dropped their price target on Definitive Healthcare from $4.50 to $3.00 and set a “neutral” rating for the company in a research report on Tuesday, March 4th. Stephens assumed coverage on Definitive Healthcare in a report on Friday, December 20th. They issued an “equal weight” rating and a $5.00 target price for the company. Barclays reduced their price target on Definitive Healthcare from $4.00 to $3.00 and set an “underweight” rating on the stock in a report on Monday, March 3rd. Finally, Needham & Company LLC reissued a “hold” rating on shares of Definitive Healthcare in a report on Thursday, January 16th. Two analysts have rated the stock with a sell rating, seven have given a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $5.35.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.